Skip to main content

VA to Use Cepheid's Pathogen Tests in Hospitals

NEW YORK (GenomeWeb News) - Cepheid has inked two contracts with the Veterans Affairs Federal Supply Service Schedule to supply VA hospitals with its pathogen tests and its GeneXpert systems, and another with a Veteran's hospital chain in the northern Midwest, the company said today.
 
Under the Federal Supply agreements, Cepheid will supply its GeneXpert systems and its methicillin-resistant Staphylococcus aureus detection test, Xpert MRSA.
 
In a separate agreement, Cepheid also will supply the Veterans Integrated Services Network 12, also called the Great Lakes Health Care System, with the Xpert MRSA tests and the GeneXpert systems. The company said VISN 12 plans to conduct around 40,000 of the MRSA tests each year to help manage infection control.
 
Financial terms of the agreements were not released.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.